In Zheng et al.'s study, PDTC was used to block NF-κB to explain the protective effects of chronic resveratrol treatment on vascular inflammatory injury in streptozotocin-induced type 2 diabetic rats [39]. This evidence concerns the gene NFKB1 and type 2 diabetes mellitus.